Bishal Gyawali
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
Bishal Gyawali
Jul 26, 2024, 08:55 |
Blog
Michelle Li: The Common Sense Oncology movement is one to which we should all belong
Michelle Li, Breast cancer fellow at Peter Mac Cancer Centre, shared on X about an article…
Jul 26, 2024, 06:54 |
Insight
Discussions around updated OS data from Aegean Trial
Discussions around updated OS data from Aegean Trial Amol Akhade shared a post on X:…
Jul 24, 2024, 15:42 |
Blog
Bishal Gyawali: Explaining cancer in simple terms isn’t easy
Bishal Gyawali shared a post on LinkedIn: "Explaining cancer in simple terms isn’t easy. This…
Jul 18, 2024, 09:04 |
Blog
Bishal Gyawali: My thoughts on the NADINA trial
Bishal Gyawali shared a post on X: "My thoughts on the NADINA trial." . Further…
Jul 18, 2024, 07:11 |
Insight
Bishal Gyawali: Quality of Life reporting remains disappointing even for those trials that lead to drug approvals
Bishal Gyawali shared a post on X about a recent paper by Medhavi Gupta et…
Jul 5, 2024, 01:33 |
Blog
Aruni Ghose: A MUST READ - penned down by Mona Hassan and Akash Maniam
Aruni Ghose shared a post by Akash Maniam, Medical Oncologist at Portsmouth Hospitals University NHS…
Jun 28, 2024, 11:54 |
Career
Dr. Khaled Zaza appointed Head of Department of Oncology at Queen's University Faculty of Health Sciences
Bishal Gyawali shared on X: . "What an amazing happy…
Jun 27, 2024, 12:11 |
Insight
Patrick Forde: What is an acceptable rate of crossover?
Patrick Forde, Co-Director of the Division of Upper Aerodigestive Malignancies Sidney Kimmel Comprehensive Cancer Center at…
Jun 24, 2024, 02:11 |
Blog
Bishal Gyawali: Very productive meeting of the MCBS working group
Bishal Gyawali shared on X: . "We had a…
Jun 23, 2024, 08:42 |
Blog
Common Sense Oncology: Equity, Value, and Outcomes That Matter
Estela Rodriguez posted on X: "Definitely a chapter to bookmark ASCO Ed Book: Common Sense…
Jun 23, 2024, 03:10 |
Blog
Bishal Gyawali: Looking forward to speaking at the Atlantic Canada Oncology Group meeting
Bishal Gyawali shared on X: "I’m very much looking forward to speaking at the Atlantic…
Jun 15, 2024, 08:57 |
Blog
Bishal Gyawali: Proud moment as a teacher
Fabio Moraes shared a post by Bishal Gyawali on X/Twitter: "Exciting times at Queen’s Global Oncology…
Jun 14, 2024, 05:32 |
Blog
Dr. Andrew Craig on $25 million gift from Cara and Murray Sinclair - Queen's Health Sciences
Bishal Gyawali shared a post by Queen's Health Sciences on X/Twitter: "Amazing news for us at The…
Jun 12, 2024, 15:37 |
Societies
Giuseppe Curigliano has been appointed as the President Elect of ESMO
The European Society for Medical Oncology (ESMO) has announced the results of its presidential election.…
Jun 9, 2024, 10:03 |
Opinion
Luis Castelo-Branco: We need serious reflections on futile/marginal expected benefit when designing a trial
Bishal Gyawali shared a post by Luis Castelo-Branco, Medical Oncologist and doctor of public health at…
Jun 7, 2024, 12:00 |
Blog
Bishal Gyawali: Many thoughts on LAURA trial
Bishal Gyawali, Associate Professor at Queen’s University, shared a post on X/Twitter: ''Many thoughts on…
Jun 6, 2024, 07:08 |
Societies
Rafeh Naqash: Don’t miss Bishal Gyawali's approach of how to evaluate data
Bishal Gyawali, Associate Professor at Queen’s University, recently shared a post by Rafeh Naqash, Assistant…
Jun 5, 2024, 11:36 |
Blog
Bishal Gyawali: An important clarification for the ASCO24 audience regarding PFS
Bishal Gyawali, Associate Professor at Queen’s University, shared on X/Twitter: "An important clarification for the ASCO24…
Jun 5, 2024, 05:34 |
Blog
Bishal Gyawali: Drop by poster board number 62 where Dr. Kristin Wright is
Bishal Gyawali, Associate Professor at Queen’s University, shared a post on X: “Hey ASCO24 crowd,…
Jun 4, 2024, 14:59 |
Societies
15 Posts From ASCO24 Day 4 You Should Not Miss!
The 2024 American Society of Clinical Oncology (ASCO) Annual Meeting is being held from May…
Jun 3, 2024, 11:40 |
Blog
Bishal Gyawali: Watch out for this rising superstar, Marco Buttigieg from Queen's University
Bishal Gyawali, Associate Professor at Queen's University, shared a post on X: …
Jun 3, 2024, 07:55 |
Societies
Bishal Gyawali: The Conquer Cancer, the ASCO Foundation's Grants and Awards ceremony is my favorite event at ASCO
Bishal Gyawali, Associate Professor in Medical Oncology and Public Health Sciences in the Division of…
Jun 2, 2024, 23:36 |
Societies
Bishal Gyawali: Thank you Conquer Cancer, the ASCO Foundation for the opportunity to share my experience
Bishal Gyawali, Associate Professor in Medical Oncology and Public Health Sciences in the Division of…
Jun 2, 2024, 11:32 |
Blog
Bishal Gyawali: Please don’t fall into the trap of hype listening to 'celebrity' experts
John Mandrola, Cardiac electrophysiologist at Baptist Health in Louisville, writer at Medscape and host of…
Jun 2, 2024, 09:09 |
Societies
15 Posts From ASCO24 Day 2 You Should Not Miss!
The 2024 American Society of Clinical Oncology (ASCO) Annual Meeting is being held from May…
Jun 1, 2024, 11:04 |
Societies
Omar Abdihamid: Common Sense Oncology will be at this year's ASCO annual meeting in Chicago
Omar Abdihamid, Clinical Oncology Specialist at HCGCCK Cancer Centre, recently shared on LinkedIn: "Common Sense…
May 31, 2024, 22:22 |
Societies
Enrique Soto: Take a look at our Educational Book Chapter on your flight to Chicago
Enrique Soto shared a post on X: "If you need something to read on your…
May 31, 2024, 17:19 |
Insight
Bishal Gyawali: Getting ready for ASCO24? Beware of experts celebrating P-values!
Bishal Gyawali, Associate Professor in Medical Oncology and Public Health Sciences in the Division of…
May 31, 2024, 17:00 |
Societies
Bishal Gyawali: Hello ASCO24 attendees, please don’t fall into the trap of hype listening to “celebrity” experts
Bishal Gyawali, Associate Professor in Medical Oncology and Public Health Sciences in the Division of…
May 30, 2024, 09:09 |
Blog
Bishal Gyawali: Common Sense Oncology chapter is now live in ASCO Ed Book
Bishal Gyawali, Associate Professor in Medical Oncology and Public Health Sciences in the Division of…
May 23, 2024, 14:37 |
Insight
Bishal Gyawali: Interesting study on survival outcomes for participants of clinical trials
Bishal Gyawali, Associate Professor in Medical Oncology and Public Health Sciences in the Division of…
May 19, 2024, 05:46 |
Blog
Edward Christopher Dee: We highlight success stories in global oncology
Edward Christopher Dee, Resident Physician in Radiation Oncology at Memorial Sloan Kettering Cancer Center, shared…
May 14, 2024, 07:26 |
Blog
Bishal Gyawali: A great episode with so much information and fun
Bishal Gyawali, Associate Professor in Medical Oncology and Public Health Sciences in the Division of…
May 13, 2024, 14:54 |
Blog
Luca De Fiore: Forward's annual meeting is approaching
Luca De Fiore, managing director of Il Pensiero Scientifico Editore scientific publishing company, shared on X/Twitter:…
May 13, 2024, 05:19 |
Opinion
Bishal Gyawali: Thank you very much Diana Romero, for visiting us the Queen's University Department of Oncology in Kingston
Bishal Gyawali, An associate professor in medical oncology and public health sciences, and scientist in the…
May 11, 2024, 02:10 |
Blog
Bishal Gyawali: How to read a systematic review and meta-analysis
Bishal Gyawali, Associate Professor in Medical Oncology and Public Health Sciences in the Division of…
May 8, 2024, 00:09 |
Blog
Bishal Gyawali: My journal club on DYNAMIC trial study
Bishal Gyawali, Associate Professor in Medical Oncology and Public Health Sciences in the Division of…
May 7, 2024, 04:25 |
Blog
Bishal Gyawali: Mission Red+White flags
Bishal Gyawali, An associate professor in medical oncology and public health sciences, and scientist in the…
May 5, 2024, 15:44 |
Blog
Julie Gralow: Common Sense Oncology meeting in Montreal
Julie Gralow shared on X/Twitter: "Common Sense Oncology meeting kicking off in Montreal with Bishal…
May 3, 2024, 04:36 |
Blog
Grand rounds lecture from Dr. Chris Booth and Bishal Gyawali - Common Sense Oncology
Common Sense Oncology shared on X/Twitter: "As a primer on CSO, here is a record of…
May 1, 2024, 06:11 |
Blog
Bishal Gyawali: Wonderful 'graduation gift' from the ASCO Leadership Development Program
Bishal Gyawali, Associate Professor in Medical Oncology and Public Health Sciences in the Division of Cancer…
May 1, 2024, 00:38 |
Positive
Bishal Gyawali: Nothing makes me happier than seeing the growth of my students
Bishal Gyawali, Associate Professor in Medical Oncology and Public Health Sciences in the Division of…
Apr 28, 2024, 15:46 |
Blog
Bishal Gyawali: I know patients have scanxiety but so do oncologists
Bishal Gyawali, Associate Professor in Medical Oncology and Public Health Sciences in the Division of…
Apr 27, 2024, 15:59 |
Blog
Bishal Gyawali: We need to extend the concept of choosing wisely to clinical trials as well
Bishal Gyawali, Associate Professor in Medical Oncology and Public Health Sciences in the Division of…
Apr 19, 2024, 18:30 |
Blog
Bishal Gyawali: Questions to ask when OS has improved
Bishal Gyawali, Associate Professor in Medical Oncology and Public Health Sciences in the Division of…
Apr 18, 2024, 13:52 |
Blog
Bishal Gyawali: Sometimes we harm the patients by lowering the bar simply because the disease is bad
Bishal Gyawali, Associate professor in medical oncology and public health sciences in the Division of…
Apr 18, 2024, 10:16 |
Insight
Luis Castelo-Branco: How to define "experts", and "specialists" in certain areas?
Luis Castelo-Branco, Medical Oncologist, Scientific and Medical Division Fellow at ESMO - European Society for…
Apr 15, 2024, 12:37 |
Blog
Bishal Gyawali: Everything I wanted patients to know about cancer clinical trials
Bishal Gyawali, Associate professor in medical oncology and public health sciences in the Division of…
Apr 13, 2024, 12:44 |
Opinion
Bishal Gyawali: Quiz: Who wrote the draft of the manuscript?
Bishal Gyawali, Associate professor in medical oncology and public health sciences at Queen’s University, shared…
Apr 12, 2024, 13:21 |
Blog
Bishal Gyawali: The most important video I’ve made for early career academics starting to do peer review
Bishal Gyawali, Associate Professor at Queen’s University, shared on X/Twitter: "The most important video I’ve…
Apr 11, 2024, 17:21 |
Opinion
Bishal Gyawali: A crash course on surrogate endpoints in oncology and their use for regulatory approval
Bishal Gyawali, Associate Professor at Queen's University, shared a post on X: "A crash course…
Apr 11, 2024, 13:03 |
Opinion
Bishal Gyawali: Challenges faced by oncologists in training in LMIC
Bishal Gyawali, Assistant Professor at University at Albany School of Public Health, shared on X/Twitter: "Challenges…
Apr 5, 2024, 08:35 |
Insight
Bishal Gyawali: Why 'number of cancer drugs approved' is a poor surrogate for measuring policy success
Alvaro Carrascal, Assistant Professor at University at Albany School of Public Health, shared a post…
Apr 4, 2024, 12:31 |
Blog
Bishal Gyawali: Financial toxicity in lung cancer, World Conference on Lung Cancer, 2018
Bishal Gyawali, Associate Professor in the Department of Oncology and Department of Public Health Sciences at…
Apr 2, 2024, 21:08 |
Blog
Bishal Gyawali: Dr. Gralow has some of the most amazing stories from her global oncology career
Bishal Gyawali, Associate Professor and Medical Oncologist at Queen’s University, shared a post on X/Twitter: “Dr. Gralow…
Mar 30, 2024, 14:53 |
Blog
Julie Gralow: Super fun and productive visit to Kingston and Queen's University Faculty of Health Sciences, Queen's University Department of Oncology
Julie Gralow recently shared on X: "Super fun and productive visit to Kingston and Queen's University…
Mar 22, 2024, 23:26 |
Insight
Bishal Gyawali: The totality of evidence remains against routine adoption of adjuvant cdk4/6 as the default SOC
Bishal Gyawali, Associate Professor and Medical Oncologist at Queen’s University, shared a post by Mark Bolton, Radiation Oncologist…
Mar 21, 2024, 16:09 |
Insight
Bishal Gyawali: A pleasure to write this editorial with the brilliant Nina Niu Sanford on how to manage FCOI in oncology
Bishal Gyawali, Associate Professor and Medical Oncologist at Queen’s University, shared a post on X/Twitter: “Hot…
Feb 24, 2024, 10:59 |
Societies
Bishal Gyawali: We had a very lively JSMO and ESMO joint symposium
Bishal Gyawali, Associate Professor and Medical Oncologist at Queen’s University, shared a post on X/Twitter: "We…
Feb 15, 2024, 18:35 |
Insight
Nina Niu Sanford: The best way to advocate for radiotherapy is through better evidence demonstrating the value of our modality
Nina Niu Sanford, Assistant Professor of Radiation Oncology at UT Southwestern Medical Center, shared an…
Feb 14, 2024, 19:39 |
Drugs
Bishal Gyawali: A pseudo-innovation for which you get to pay more without any added benefits
Bishal Gyawali, Associate Professor and Medical Oncologist at Queen’s University, shared a post on X/Twitter: "Read…
Feb 8, 2024, 22:27 |
Blog
Bishal Gyawali: We are super excited to announce our first Common Sense Oncology fellow, Haydeé Verduzco
Bishal Gyawali, Associate Professor and Medical Oncologist at Queen’s University, shared a post on X/Twitter: “We…
Feb 6, 2024, 15:29 |
Blog
Bishal Gyawali: Chris Booth and I discuss how 25 years of "innovation" in the treatment of metastatic pancreatic cancer has barely budged the survival rates for this still lethal disease
Feb 2, 2024, 14:33 |
Blog
Bishal Gyawali: How strange the academic world is
Bishal Gyawali, Associate Professor and Medical Oncologist at Queen's University, shared a post on X/Twitter: "Both…
Feb 2, 2024, 12:25 |
Opinion
Bishal Gyawali: Want to get your mind blown about how insane cancer drug prices have become?
Bishal Gyawali, Medical Oncologist and Assistant Professor at Queen’s University, shared on X: "Want to…
Feb 1, 2024, 22:48 |
Blog
Bishal Gyawali: Very fascinating interview in Endpoints News with Janet Woodcock as she retires from the FDA
Bishal Gyawali, Medical Oncologist and Assistant Professor at Queen’s University, shared on X: "Very fascinating…
Jan 26, 2024, 17:17 |
Societies
30 Posts Not To Miss From ASCO GI24
The ASCO Gastrointestinal Cancer Symposium (GI24) took place from the 18th to the 20th of…
Jan 6, 2024, 12:09 |
Insight
Bishal Gyawali: Here is a list of our top 10 publications from 2023
Bishal Gyawali, Medical Oncologist and Assistant Professor at Queen’s University, shared on X: "Happy New…
Nov 28, 2023, 17:12 |
Blog
Bishal Gyawali: We examine the ADAURA trial with a global oncology lens
Bishal Gyawali, Medical Oncologist and Assistant Professor at Queen's University, shared on X/Twitter: "Our new…
Nov 27, 2023, 15:31 |
Blog
Ophira Ginsburg: A must-read for people interested in advancing high-quality, patient-centered, equity-oriented cancer clinical trials
Ophira Ginsburg shared a post by Bishal Gyawali, Medical Oncologist and Associate Professor at Queen's…
Nov 26, 2023, 11:39 |
Blog
Amol Akhade: Showing lacunas in ADAURA is considered as SIN in oncology
Dr Amol Akhade, Consultant medical oncologist/hematooncologist at Suyog Cancer Clinics, posted on X/Twitter: "Showing lacunas…
Nov 24, 2023, 01:03 |
Blog
Bishal Gyawali: We urge to exercise some caution before we start treating “pre-patients” for cancer risk factors!
Bishal Gyawali, Associate Professor at Queen's University, made the following post on LinkedIn: "In our…
Nov 19, 2023, 17:00 |
Blog
Olubukola Ayodele: This meeting has definitely fueled my passion for global oncology
Olubukola Ayodele, Head of Breast Cancer Clinical Trials at the Leicester Cancer Research Centre, shared…
Nov 4, 2023, 17:25 |
Positive
Susie Stanway: This superb talk by Bishal Gyawali is well worth a listen if you’re aspiring to have a research career
Susie Stanway, Co-Founder of London Global Cancer Week, shared on LinkedIn: “This superb talk by…
Nov 3, 2023, 11:25 |
Blog
Ashwini Gupta: Research method workshop: From writing proposal to getting manuscript published
Ashwini Gupta, USMLE Aspirant, recently posted on LinkedIn. "Day 1 of ecancer Kathmandu 2023. Research…
Oct 8, 2023, 18:03 |
Insight
Bishal Gyawali: Kudos to the FDA for being proactive and swift in making withdrawal recommendations in recent years.
Bishal Gyawali, Associate Professor at Queen's University, shared on X/Twitter: "When a drug that previously…
Oct 7, 2023, 18:27 |
Opinion
Bishal Gyawali: This offers a good lesson on why oncology KOLs are not always the best person to interpret the results of a trial.
Quoting Bishal Gyawali, Associate Professor at Queen’s University, on LinkedIn: “This is from FDA’s ODAC…
Oct 3, 2023, 18:07 |
Blog
Guilherme Perini: Would love to hear colleagues from Low- or Middle-Income Countries.
Guilherme Perini, Hematologist at Israelita Albert Einstein Hospital, shared a post by Bishal Gyawali on…
Sep 26, 2023, 19:21 |
Blog
Bishal Gyawali: We are pleased and proud to announce the inaugural Common Sense Oncology Fellowship in Cancer Policy based at the Division of Cancer Care and Epidemiology in Kingston, Ontario.
Sep 12, 2023, 19:59 |
Insight
Bishal Gyawali: In this perspective piece out in NEJM today, we discuss finding the right balance for accelerated approval of cancer drugs in the context of the recently proposed FDA guidance.
Aug 30, 2023, 17:48 |
Blog
Bishal Gyawali: The tables in this paper will be supremely useful to anyone looking for a list of cancer drugs approved for breast cancer in the last decade.
In a post by Bishal Gyawali, an Associate Professor in medical oncology and public health…
Aug 29, 2023, 21:37 |
Insight
Bishal Gyawali: Congratulations to Dr. Abhenil Mittal and our Queen's University Department of Oncology resident Dr. Kristin Wright on the publication of this important paper.
Aug 23, 2023, 17:23 |
Opinion
Bishal Gyawali: When a new trial is published or presented, the first thing you do should not be tweet "congratulations" at the author...
Bishal Gyawali, an Associate Professor at the Division of Cancer Care and Epidemiology at Queen’s…
Aug 5, 2023, 18:32 |
Blog
Huge room for improvement to be made in equitable access to proven current and new treatments for all - Sarah Tregenza
Great first day at the Medical Oncology Group of Australia 2023 ASM with the Pierre Fabre Medical Care…
Aug 3, 2023, 18:27 |
Blog
Announcing the launch of our website oncolegybg.com! - Bishal Gyawali
Announcing the launch of our website! All thanks to my super star undergrad student and…
Jul 22, 2023, 18:12 |
Stories
This is so heart warming - Bishal Gyawali
This is so heart warming. It made my day. Specially considering it came from Khalid…
Jul 18, 2023, 20:06 |
Blog
I argue that crossover should not be “allowed”- they should either be “mandated” or “prohibited” - Bishal Gyawali
Hot off the press in NatureRevClinOncol! Using examples from trials presented at ASCO23, in this…
Jul 16, 2023, 23:17 |
Opinion
This Common Sense Oncology (CSO) manifesto is a must read for the oncology community - Nina Niu Sanford
Quoting Dr. Nina Niu Sanford on Twitter, "This Common Sense Oncology (CSO) manifesto is a…
All:
88
Posts:
1 - 100
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube